Your search returned 5 results.

Results
	1.	Lucrative niches: how drugs for rare diseases became lifeline for companies. [electronic resource] by Anand, Geeta Producer: 20060425 In: Wall Street journal (Eastern ed.) p. A1, A18 Availability: No items available. Save to lists Add to cart (remove)
	2.	How drug's rebirth as treatment for cancer fueled price rises. [electronic resource] by Anand, Geeta Producer: 20050222 In: Wall Street journal (Eastern ed.) p. A1, A18 Availability: No items available. Save to lists Add to cart (remove)
	3.	Support system: through charities, drug makers help people--and themselves. [electronic resource] by Anand, Geeta Producer: 20060420 In: Wall Street journal (Eastern ed.) p. A1, A10 Availability: No items available. Save to lists Add to cart (remove)
	4.	Why Genzyme can charge so much for Cerezyme. [electronic resource] by Anand, Geeta Producer: 20060420 In: Wall Street journal (Eastern ed.) p. A15 Availability: No items available. Save to lists Add to cart (remove)
	5.	How some patients in new-drug trials can get cut off. [electronic resource] by Anand, Geeta Producer: 20040429 In: Wall Street journal (Eastern ed.) p. A1, A11 Availability: No items available. Save to lists Add to cart (remove)

Refine your search